logo-loader
viewDyadic International Inc

Dyadic International taps Ping Rawson as chief financial officer

Rawson previously served as the Dyadic’s chief accounting officer after joining the company in 2016

Handshake
In her new role, Rawson (pictured) will oversee all accounting, financial reporting, treasury and taxes

Dyadic International Inc (NASDAQ:DYAI), a biopharmaceutical Company, is making changes to its executive team by promoting Ping Rawson to chief financial officer.

Rawson previously served as the Dyadic’s chief accounting officer after joining the Company in 2016.

In her new role, Rawson will oversee all accounting, financial reporting, treasury and taxes at the Jupiter, Florida-based Company. She will also work with the executive team to set long-term goals and make operational decisions.

READ: Dyadic International to ring the Nasdaq closing bell to celebrate recent listing, spotlight its tech

The Company’s stock climbed 7.2% to $6.43.

"Since joining Dyadic, Ping has made significant contributions to our Company, initially in her role as Director of Financial Reporting and, more recently, as Chief Accounting Officer. She has taken on increased responsibilities, and demonstrated capabilities in both business and management skills," CEO Mark Emalfarb said. "This past year was a transformational one for Dyadic with our SEC registration and uplisting to Nasdaq. Ping's efforts have been critical to our success."

Dyadic is developing a biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Dyadic International Inc

Price: 5.75 USD

NASDAQ:DYAI
Market: NASDAQ
Market Cap: $156.48 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Dyadic International Inc named herein, including the promotion by the Company of Dyadic International Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Dyadic touts recent collaborations, 3Q highlights at Jefferies London...

Dyadic International Inc (NASDAQ:DYAI) CEO Mark Emalfarb and CCO Matthew Jones tell Proactive's Andrew Scott the duo are in London for the Jefferies London Healthcare Conference, the biotech's third year attending.  Emalfarb and Jones say the Florida-based biotech is touting its recent...

3 days, 12 hours ago

2 min read